regency medicine ltd.

Live MatureSmallLow

regency medicine ltd. Company Information

Share REGENCY MEDICINE LTD.

Company Number

SC189762

Shareholders

gem care 1 ltd

Group Structure

View All

Industry

Other human health activities

 

Registered Address

3 castle court, carnegie campus, dunfermline, fife, KY11 8PB

regency medicine ltd. Estimated Valuation

£2m

Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £2m based on a Turnover of £4.3m and 0.48x industry multiple (adjusted for size and gross margin).

regency medicine ltd. Estimated Valuation

£486.2k

Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £486.2k based on an EBITDA of £133.1k and a 3.65x industry multiple (adjusted for size and gross margin).

regency medicine ltd. Estimated Valuation

£4.9m

Pomanda estimates the enterprise value of REGENCY MEDICINE LTD. at £4.9m based on Net Assets of £1.9m and 2.49x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Regency Medicine Ltd. Overview

Regency Medicine Ltd. is a live company located in dunfermline, KY11 8PB with a Companies House number of SC189762. It operates in the other human health activities sector, SIC Code 86900. Founded in September 1998, it's largest shareholder is gem care 1 ltd with a 100% stake. Regency Medicine Ltd. is a mature, small sized company, Pomanda has estimated its turnover at £4.3m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Regency Medicine Ltd. Health Check

Pomanda's financial health check has awarded Regency Medicine Ltd. a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

5 Strong

positive_score

1 Regular

positive_score

6 Weak

size

Size

annual sales of £4.3m, make it larger than the average company (£652.6k)

£4.3m - Regency Medicine Ltd.

£652.6k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (6%)

2% - Regency Medicine Ltd.

6% - Industry AVG

production

Production

with a gross margin of 21.9%, this company has a higher cost of product (38.9%)

21.9% - Regency Medicine Ltd.

38.9% - Industry AVG

profitability

Profitability

an operating margin of 2.4% make it less profitable than the average company (5.5%)

2.4% - Regency Medicine Ltd.

5.5% - Industry AVG

employees

Employees

with 47 employees, this is above the industry average (17)

47 - Regency Medicine Ltd.

17 - Industry AVG

paystructure

Pay Structure

on an average salary of £26k, the company has an equivalent pay structure (£26k)

£26k - Regency Medicine Ltd.

£26k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £90.4k, this is more efficient (£48.3k)

£90.4k - Regency Medicine Ltd.

£48.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 133 days, this is later than average (23 days)

133 days - Regency Medicine Ltd.

23 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 14 days, this is quicker than average (19 days)

14 days - Regency Medicine Ltd.

19 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (15 days)

0 days - Regency Medicine Ltd.

15 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 22 weeks, this is less cash available to meet short term requirements (112 weeks)

22 weeks - Regency Medicine Ltd.

112 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 12.3%, this is a lower level of debt than the average (26.6%)

12.3% - Regency Medicine Ltd.

26.6% - Industry AVG

REGENCY MEDICINE LTD. financials

EXPORTms excel logo

Regency Medicine Ltd.'s latest turnover from October 2023 is estimated at £4.3 million and the company has net assets of £1.9 million. According to their latest financial statements, Regency Medicine Ltd. has 47 employees and maintains cash reserves of £58.4 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Turnover4,250,6703,786,1443,604,0383,980,8462,714,6272,477,6512,630,5322,358,0252,778,7281,811,2181,719,672272,874348,8193,213,8080
Other Income Or Grants000000000000000
Cost Of Sales3,318,3992,966,3822,879,0653,133,2572,133,1151,948,4992,002,4611,797,0662,168,2901,385,7531,311,002198,606250,6222,299,0040
Gross Profit932,271819,762724,973847,590581,512529,153628,071560,959610,438425,465408,67074,26898,196914,8040
Admin Expenses829,988666,784644,852653,895488,912537,476477,235362,738428,377322,897295,557-25,340761,676502,672-1,596,448
Operating Profit102,283152,97880,121193,69592,600-8,323150,836198,221182,061102,568113,11399,608-663,480412,1321,596,448
Interest Payable000000000000000
Interest Receivable2,3751,18440322659557611941744735751,3072,020837
Pre-Tax Profit104,657154,16280,160193,72792,864-8,228150,893198,283182,255102,742113,586100,183-662,173414,1511,597,285
Tax-26,164-29,291-15,230-36,808-17,6440-28,670-39,656-36,451-21,576-26,125-24,0440-115,962-447,240
Profit After Tax78,493124,87164,930156,91975,220-8,228122,223158,626145,80481,16687,46176,139-662,173298,1891,150,045
Dividends Paid000000000000000
Retained Profit78,493124,87164,930156,91975,220-8,228122,223158,626145,80481,16687,46176,139-662,173298,1891,150,045
Employee Costs1,220,5451,122,5121,081,0051,056,2741,086,343934,6741,056,1311,003,318808,734582,597579,668106,476126,751965,1990
Number Of Employees474646464843494938272756470
EBITDA*133,057182,885111,577227,768125,22725,927181,997231,001212,224132,475116,134125,720-637,244437,4801,622,709

* Earnings Before Interest, Tax, Depreciation and Amortisation

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Tangible Assets611,465628,531652,304679,042690,586710,498722,335737,046750,157770,350791,653800,886822,216840,516864,219
Intangible Assets000000000000000
Investments & Other000000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets611,465628,531652,304679,042690,586710,498722,335737,046750,157770,350791,653800,886822,216840,516864,219
Stock & work in progress3,0003,0003,0003,0003,0003,0003,1983,0003,0003,0003,0003,0003,000950950
Trade Debtors1,551,1081,479,8951,326,4811,380,503881,830833,221841,908698,597548,589329,335293,83715,60539,518625,525415,079
Group Debtors000000000000000
Misc Debtors000000000000000
Cash58,40932,05073,1896,41358,47012,06213,37632,24816,74460,8058,852180,35149,739473,097334,708
misc current assets00000000000370000
total current assets1,612,5171,514,9451,402,6701,389,916943,300848,283858,482733,845568,333393,140305,689199,32692,2571,099,572750,737
total assets2,223,9822,143,4762,054,9742,068,9581,633,8861,558,7811,580,8171,470,8911,318,4901,163,4901,097,3421,000,212914,4731,940,0881,614,956
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 134,74087,27278,187115,43487,28187,396101,204113,501121,166112,062126,592119,831110,442166,862115,082
Group/Directors Accounts000000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities000000000000000
total current liabilities134,74087,27278,187115,43487,28187,396101,204113,501121,166112,062126,592119,831110,442166,862115,082
loans000000000000000
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities117,424162,879208,333250,000000000000307,241332,303
provisions21,93321,93321,93321,93321,93321,93321,93321,93320,49320,40120,88917,98117,77017,55117,326
total long term liabilities139,357184,812230,266271,93321,93321,93321,93321,93320,49320,40120,88917,98117,770324,792349,629
total liabilities274,097272,084308,453387,367109,214109,329123,137135,434141,659132,463147,481137,812128,212491,654464,711
net assets1,949,8851,871,3921,746,5211,681,5911,524,6721,449,4521,457,6801,335,4571,176,8311,031,027949,861862,400786,2611,448,4341,150,245
total shareholders funds1,949,8851,871,3921,746,5211,681,5911,524,6721,449,4521,457,6801,335,4571,176,8311,031,027949,861862,400786,2611,448,4341,150,245
Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Operating Activities
Operating Profit102,283152,97880,121193,69592,600-8,323150,836198,221182,061102,568113,11399,608-663,480412,1321,596,448
Depreciation30,77429,90731,45634,07332,62734,25031,16132,78030,16329,9073,02126,11226,23625,34826,261
Amortisation000000000000000
Tax-26,164-29,291-15,230-36,808-17,6440-28,670-39,656-36,451-21,576-26,125-24,0440-115,962-447,240
Stock00000-198198000002,0500950
Debtors71,213153,414-54,022498,67348,609-8,687143,311150,008219,25435,498278,232-23,913-586,007210,446415,079
Creditors47,4689,085-37,24728,153-115-13,808-12,297-7,6659,104-14,5306,7619,389-56,42051,780115,082
Accruals and Deferred Income000000000000000
Deferred Taxes & Provisions00000001,44092-4882,90821121922517,326
Cash flow from operations83,1489,265113,122-279,56058,85921,004-2,47935,112-34,28560,383-178,554135,189-109,488163,077891,848
Investing Activities
capital expenditure-13,708-6,134-4,718-22,529-12,715-22,413-16,450-19,669-9,970-8,6046,212-4,782-7,936-1,645-890,480
Change in Investments000000000000000
cash flow from investments-13,708-6,134-4,718-22,529-12,715-22,413-16,450-19,669-9,970-8,6046,212-4,782-7,936-1,645-890,480
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000000000000
Other Short Term Loans 000000000000000
Long term loans000000000000000
Hire Purchase and Lease Commitments000000000000000
other long term liabilities-45,455-45,454-41,667250,00000000000-307,241-25,062332,303
share issue00000000000000200
interest2,3751,18440322659557611941744735751,3072,020837
cash flow from financing-43,080-44,270-41,627250,032265955761194174473575-305,934-23,042333,340
cash and cash equivalents
cash26,359-41,13966,776-52,05746,408-1,314-18,87215,504-44,06151,953-171,499130,612-423,358138,389334,708
overdraft000000000000000
change in cash26,359-41,13966,776-52,05746,408-1,314-18,87215,504-44,06151,953-171,499130,612-423,358138,389334,708

regency medicine ltd. Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for regency medicine ltd.. Get real-time insights into regency medicine ltd.'s credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Regency Medicine Ltd. Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for regency medicine ltd. by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in KY11 area or any other competitors across 12 key performance metrics.

regency medicine ltd. Ownership

REGENCY MEDICINE LTD. group structure

Regency Medicine Ltd. has no subsidiary companies.

Ultimate parent company

1 parent

REGENCY MEDICINE LTD.

SC189762

REGENCY MEDICINE LTD. Shareholders

gem care 1 ltd 100%

regency medicine ltd. directors

Regency Medicine Ltd. currently has 1 director, Mr Mahendran Bakeirathan serving since Apr 2011.

officercountryagestartendrole
Mr Mahendran BakeirathanEngland50 years Apr 2011- Director

P&L

October 2023

turnover

4.3m

+12%

operating profit

102.3k

0%

gross margin

22%

+1.3%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

October 2023

net assets

1.9m

+0.04%

total assets

2.2m

+0.04%

cash

58.4k

+0.82%

net assets

Total assets minus all liabilities

regency medicine ltd. company details

company number

SC189762

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

September 1998

age

27

incorporated

UK

ultimate parent company

accounts

Unaudited Abridged

last accounts submitted

October 2023

previous names

N/A

accountant

-

auditor

-

address

3 castle court, carnegie campus, dunfermline, fife, KY11 8PB

Bank

-

Legal Advisor

-

regency medicine ltd. Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to regency medicine ltd.. Currently there are 3 open charges and 1 have been satisfied in the past.

regency medicine ltd. Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for REGENCY MEDICINE LTD.. This can take several minutes, an email will notify you when this has completed.

regency medicine ltd. Companies House Filings - See Documents

datedescriptionview/download